Jinal N. Bhiman

19.9k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Jinal N. Bhiman is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Jinal N. Bhiman has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Virology. Recurrent topics in Jinal N. Bhiman's work include SARS-CoV-2 and COVID-19 Research (13 papers), HIV Research and Treatment (9 papers) and COVID-19 epidemiological studies (8 papers). Jinal N. Bhiman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), HIV Research and Treatment (9 papers) and COVID-19 epidemiological studies (8 papers). Jinal N. Bhiman collaborates with scholars based in South Africa, United States and Australia. Jinal N. Bhiman's co-authors include Penny L. Moore, Lynn Morris, Constantinos Kurt Wibmer, Bronwen E. Lambson, Tandile Hermanus, Anne von Gottberg, Cheryl Cohen, Carolyn Williamson, Salim S. Abdool Karim and Karin van den Berg and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Jinal N. Bhiman

24 papers receiving 1.5k citations

Hit Papers

SARS-CoV-2 501Y.V2 escapes neutralization by South Africa... 2021 2026 2022 2024 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinal N. Bhiman South Africa 13 937 536 411 408 240 29 1.5k
Tandile Hermanus South Africa 10 919 1.0× 679 1.3× 389 0.9× 450 1.1× 222 0.9× 24 1.5k
Constantinos Kurt Wibmer South Africa 12 972 1.0× 923 1.7× 460 1.1× 593 1.5× 296 1.2× 17 1.7k
Kshitij Wagh United States 16 568 0.6× 489 0.9× 294 0.7× 281 0.7× 173 0.7× 28 1.1k
Kevin O. Saunders United States 21 786 0.8× 696 1.3× 733 1.8× 701 1.7× 418 1.7× 58 1.9k
Andrew Fioré-Gartland United States 13 770 0.8× 102 0.2× 404 1.0× 622 1.5× 134 0.6× 37 1.4k
Chungen Pan China 17 594 0.6× 300 0.6× 230 0.6× 139 0.3× 117 0.5× 35 1.1k
Shan Su China 19 570 0.6× 172 0.3× 279 0.7× 320 0.8× 67 0.3× 45 1.1k
Frank Konings United States 15 815 0.9× 373 0.7× 168 0.4× 94 0.2× 63 0.3× 39 1.2k
Lilian Nogueira United States 12 761 0.8× 941 1.8× 231 0.6× 686 1.7× 321 1.3× 12 1.5k
Leo Heyndríckx Belgium 24 938 1.0× 1.1k 2.0× 236 0.6× 365 0.9× 143 0.6× 63 1.5k

Countries citing papers authored by Jinal N. Bhiman

Since Specialization
Citations

This map shows the geographic impact of Jinal N. Bhiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinal N. Bhiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinal N. Bhiman more than expected).

Fields of papers citing papers by Jinal N. Bhiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinal N. Bhiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinal N. Bhiman. The network helps show where Jinal N. Bhiman may publish in the future.

Co-authorship network of co-authors of Jinal N. Bhiman

This figure shows the co-authorship network connecting the top 25 collaborators of Jinal N. Bhiman. A scholar is included among the top collaborators of Jinal N. Bhiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinal N. Bhiman. Jinal N. Bhiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhiman, Jinal N., Cathrine Scheepers, Tandile Hermanus, et al.. (2025). Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern. Scientific Reports. 15(1). 5549–5549.
2.
Cohen, Cheryl, Jackie Kleynhans, Anne von Gottberg, et al.. (2024). Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021. BMC Infectious Diseases. 24(1). 336–336. 2 indexed citations
3.
Planas, Delphine, Lin Peng, Lingyi Zheng, et al.. (2024). Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants. Heliyon. 10(5). e27033–e27033.
4.
Williams, Thomas, Sandra Jackson, Ian Barr, et al.. (2023). Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020. Influenza and Other Respiratory Viruses. 17(1). e13073–e13073. 4 indexed citations
5.
Wolter, Nicole, Stefano Tempia, Anne von Gottberg, et al.. (2023). Healthcare utilization during the first two waves of the COVID-19 epidemic in South Africa: A cross-sectional household survey. PLoS ONE. 18(8). e0290787–e0290787.
6.
Yousif, Mukhlid, R. Saïd, Chinwe Juliana Iwu, et al.. (2023). SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses. Nature Communications. 14(1). 6325–6325. 26 indexed citations
8.
Walaza, Sibongile, Stefano Tempia, Anne von Gottberg, et al.. (2022). Risk Factors for Severe Coronavirus Disease 2019 Among Human Immunodeficiency Virus-Infected and -Uninfected Individuals in South Africa, April 2020–March 2022: Data From Sentinel Surveillance. Open Forum Infectious Diseases. 9(12). ofac578–ofac578. 4 indexed citations
9.
Sawry, Shobna, Nicole Wolter, Philile Mbatha, et al.. (2022). High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. International Journal of Infectious Diseases. 125. 241–249. 7 indexed citations
10.
Meiring, Susan, Jinal N. Bhiman, Jackie Kleynhans, et al.. (2022). Prolonged shedding of SARS-CoV-2 at high viral load amongst hospitalised immunocompromised persons living with HIV in South Africa. International Journal of Infectious Diseases. 116. S25–S25. 3 indexed citations
11.
Kleynhans, Jackie, Stefano Tempia, Nicole Wolter, et al.. (2021). SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021. Emerging infectious diseases. 27(12). 3020–3029. 47 indexed citations
12.
Wibmer, Constantinos Kurt, Frances Ayres, Tandile Hermanus, et al.. (2021). SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nature Medicine. 27(4). 622–625. 657 indexed citations breakdown →
13.
Ondoa, Pascale, Yenew Kebede, Marguerite Massinga Loembé, et al.. (2020). COVID-19 testing in Africa: lessons learnt. The Lancet Microbe. 1(3). e103–e104. 58 indexed citations
14.
Pooe, Ofentse Jacob, Lusisizwe Kwezi, Stoyan Stoychev, et al.. (2020). Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications. Scientific Reports. 10(1). 6201–6201. 28 indexed citations
15.
Havenar‐Daughton, Colin, Diane G. Carnathan, Archana V. Boopathy, et al.. (2019). Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization. Cell Reports. 29(7). 1756–1766.e8. 44 indexed citations
16.
Johnson, E. L., Nicole A. Doria‐Rose, Jason Gorman, et al.. (2018). Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nature Communications. 9(1). 4136–4136. 6 indexed citations
17.
Sheward, Daniel J., Valerie Bekker, Ben Murrell, et al.. (2018). HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth. Cell Host & Microbe. 24(4). 593–599.e3. 17 indexed citations
18.
Wibmer, Constantinos Kurt, Daniel J. Sheward, Jinal N. Bhiman, et al.. (2014). Viral Escape Pathways from Broadly Neutralising Antibodies Targeting the HIV Envelope Cleavage Site Enhance MPER Mediated Neutralisation. AIDS Research and Human Retroviruses. 30(S1). A20–A21. 1 indexed citations
19.
Wibmer, Constantinos Kurt, Jinal N. Bhiman, Elin S. Gray, et al.. (2013). Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes. PLoS Pathogens. 9(10). e1003738–e1003738. 144 indexed citations
20.
Moore, Penny L., Elin S. Gray, Constantinos Kurt Wibmer, et al.. (2012). Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape. Nature Medicine. 18(11). 1688–1692. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026